GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optigenex Inc (OTCPK:OPGX) » Definitions » Total Current Liabilities

Optigenex (Optigenex) Total Current Liabilities : $8.68 Mil (As of Jun. 2008)


View and export this data going back to 2004. Start your Free Trial

What is Optigenex Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Optigenex's total current liabilities for the quarter that ended in Jun. 2008 was $8.68


Optigenex Total Current Liabilities Historical Data

The historical data trend for Optigenex's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optigenex Total Current Liabilities Chart

Optigenex Annual Data
Trend Dec04 Dec05 Dec06 Dec07
Total Current Liabilities
1.10 0.54 0.52 5.02

Optigenex Quarterly Data
Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 2.09 5.02 9.93 8.68

Optigenex Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Optigenex's Total Current Liabilities for the fiscal year that ended in Dec. 2007 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.386+4.514
+Other Current Liabilities+Current Deferred Liabilities
=-0.0010000000000003+0.12
=5.02

Optigenex's Total Current Liabilities for the quarter that ended in Jun. 2008 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.415+8.182
+Other Current Liabilities+Current Deferred Liabilities
=0+0.08
=8.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Optigenex Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Optigenex's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Optigenex (Optigenex) Business Description

Traded in Other Exchanges
N/A
Address
901 Sam Rayburn Highway, Melissa, TX, USA, 75454
Optigenex Inc is an applied sciences company dedicated to solutions for healthy age management. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging.
Executives
Richard S Serbin director, 10 percent owner, officer: CEO, President & Secretary 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10022

Optigenex (Optigenex) Headlines

No Headlines